title: Bone mineral density is associated with site-specific atherosclerosis in patients with severe peripheral artery disease.
abstract: Recent studies have highlighted a significant association between the severity of atherosclerosis and bone mineral density (BMD) among healthy subjects, although its connection to angiographically determined peripheral artery disease (PAD) has never been investigated. We evaluated the connection between the angiographic severity and site specificity of peripheral atherosclerosis and osteoporosis among patients with chronic lower limb ischemia. In our cross-sectional study we investigated 172 patients with PAD. The anatomic sites of the lesions were analyzed. The severity of atherosclerosis was diagnosed using the Bollinger angiographic score (BS). BMD was measured at the lumbar spine (l-BMD) and at femoral (f-BMD) and radial (r-BMD) sites by dual-energy X-ray absorptiometry. Dyslipidemia, the level of vitamin D(3), and different bone turnover markers were also noted. Among PAD patients, regardless of the lesion site, we did not find any association between BMD and BS. Among patients with iliac disease, BS was associated with l-BMD (p = 0.038, r = -0.467) and with f-BMD (p = 0.002, r = -0.642). The level of r-BMD among patients with iliac disease was not associated with BS (p = 0.233, r = -0.306). We did not find any difference between the group of patients with and that without dyslipidemia and low or normal levels of vitamin D(3). Our results show a connection between the severity of atherosclerosis and osteoporosis among patients with PAD, specific to the site of the lesion. The findings regarding dyslipidemia, bone markers, and site specificity support the hypothesis that reduced blood flow is the key factor responsible for the inverse association of BMD with atherosclerosis.
authors.affiliation: Department of Vascular Surgery, Semmelweis University, 68 Varosmajor Street, Budapest, 1122, Hungary. fehervarimatyi@gmail.com
authors.forename: Mátyás
authors.initials: M
authors.lastname: Fehérvári
authors.forename: Hunor
authors.initials: H
authors.lastname: Sarkadi
authors.forename: Miklós
authors.initials: M
authors.lastname: Krepuska
authors.forename: Péter
authors.initials: P
authors.lastname: Sótonyi
authors.forename: György
authors.initials: G
authors.lastname: Acsády
authors.forename: László
authors.initials: L
authors.lastname: Entz
authors.forename: Péter
authors.initials: P
authors.lastname: Lakatos
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szeberin
mesh_terms: D015502:Absorptiometry, Photon; D000368:Aged; D050197:Atherosclerosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology*; D015519:Bone Density; D002762:Cholecalciferol / Q000097:blood; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000150:complications / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology; D058729:Peripheral Arterial Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology*
chemical_list: D002762:Cholecalciferol